Hasil Pencarian  ::  Simpan CSV :: Kembali

"The pharmaceutical industry is praised as a leader in high technology innovation and the creator of products that increase both longevity and quality of life for people throughout the world. Yet the industry is also reviled for its marketing and pricing practices and even its research and development priorities. This book uses the tools of economic analysis to explore the conflicting priorities and aims of the pharmaceutical industry, from both an American and worldwide perspective. This second edition includes six new chapters on emerging topics such as the broadened role of FDA regulations, alternative drugs or "nutraceuticals," and biotechnology and other industries related to pharmaceuticals. Existing chapters are fully revised and updated to include new materials. The introduction is also updated to address the volatile pace of pharmaceutical innovation and how the pharmaceutical industry has responded to the emergence of managed care. "

"This book guides the reader through FDA regulation guidelines and outlines a comprehensive strategy for cost reduction in regulatory affairs and compliance. This book explains six strategies to cost-effectively comply with FDA regulations while maintaining product safety and improving public access through cost controls. It provides useful and practical guidance through industry case studies from pharmaceutical, biotech, and medical device industries."

"The aim of this research is to provide a theoretical framework for strategic alliance behavior by firms that seek to sustain a competitive advantage The objective is to integrate the transaction cost economic explanations, strategic behavior of the firm, in investigating strategic alliance phenomena in relation to competitive positioning. The fundamental premise of this research is that inter-firm relationships are embedded within the alliance, The hyphoteses are tested by applying quantitative analysis to data collected on 108 alliances that are involved in the development of pharmaceutical companies in Asia. A full survey was mailed to executives or key individual involved in the implementation of the alliances. The results of this research confirm our framework and also indicates that when firms build relational: capital in conjunction with an integrative approach to managing conflict they are able to achieve both organizational learning and protecting core assets simultaneously, Relational capital based on mutual trust and interaction between alliance partners creates a basis for learning and know-how transfer across accross the exchange the lekage of critical know how between them. Furthermore research indicates that through learning and acquining new importang information as well as some critical capability or skill from the partner while at the same time,m being able to protect its core capabilities and its crown jewels the company will compete effectively in the market. The research makes an important contribution to the literature by determining whether strategic alliances sustain competitiveness for firms pursuing a cooperative strategy."

"Menteri Kesehatan memberikan izin kepada industri farmasi untuk melakukan kegiatan pembuatan obat atau bahan obat dan memiliki peran yang esensial dalam ketersediaan obat-obatan yang memenuhi standar, aman, bermutu, dan bermanfaat. Pada proses pembuatan obat, setiap industri farmasi harus menerapkan Cara Pembuatan Obat yang Baik (CPOB) yang bertujuan untuk menjamin obat dibuat secara konsisten, memenuhi persyaratan yang ditetapkan dan sesuai dengan tujuan penggunaannya.

---

The Minister of Health grants permission to the pharmaceutical industry to carry out activities for the manufacture of drugs or medicinal ingredients and has an essential role in the availability of medicines that meet standards, are safe, quality and useful. In the process of making drugs, each pharmaceutical industry must implement a Good Drug Manufacturing Method (GMP) which aims to ensure that the drug is made consistently, meets the requirements set and in accordance with the intended use."

"Studi ini bertujuan menganalisis dampak COVID-19 terhadap perdagangan (ekspor dan impor) pada industri farmasi di negara anggota ASEAN. Dengan menggunakan metode Pseudo Poisson Maximum Likelihood (PPML) serta data jumlah kasus kumulatif COVID-19 dan data nilai ekspor dan impor industri farmasi selama periode Januari 2019 sampai Desember 2020, hasil estimasi menunjukkan bahwa jumlah kasus terinfeksi pada negara anggota ASEAN tidak berpengaruh terhadap nilai ekspor produk farmasi negara anggota ASEAN. Adapun di sisi impor, jumlah kasus terinfeksi COVID19 kumulatif pada negara ASEAN berdampak secara positif signifikan terhadap nilai impor produk farmasi negara anggota ASEAN.

---

This study aims to analysis the impact of COVID-19 on trade (exports and imports) in the pharmaceutical industry in ASEAN member countries. By using the Pseudo Poisson Maximum Likelihood (PPML) method as well as data on the cumulative number of COVID-19 cases and data on exports and imports of the pharmaceutical industry during the period January 2019 to December 2020, the estimation results show that the number of infected cases in ASEAN member countries has no effect on export value. pharmaceutical products of ASEAN member countries. On the import side, the number of cumulative COVID-19 infected cases in ASEAN countries has a significant positive impact on the import value of pharmaceutical products from ASEAN member countries."

"This article examines patent regime in jordan particularly when it applies to pharmaceutical industry...."

"

Penelitian ini bertujuan meningkatkan efisiensi dan efektivitas perencanaan produksi serta pengendalian material di perusahaan manufaktur farmasi. Metodenya melibatkan implementasi Advance Planning System (APS) dengan API Gateway untuk production planning dan material requirements planning. Data diambil dari perusahaan farmasi di Indonesia melalui observasi dan wawancara. Hasilnya mencakup rancangan sistem informasi, seperti Entity Relationship Diagram, tabel Relational Database, Use Case Diagram, Data Flow Diagram, dan Activity Diagram. Sistem yang dikembangkan mencapai 4 tahap transformasi digital dalam proses PPIC: digitalisasi, integrasi data, dan otomatisasi proses.

---

This research aims to increase the efficiency and effectiveness of production planning and material control in pharmaceutical manufacturing companies. The method involves implementing an Advance Planning System (APS) with API Gateway for production planning and material requirements planning. Data was taken from pharmaceutical companies in Indonesia through observation and interviews. The results include information system designs, such as Entity Relationship Diagrams, Relational Database tables, Use Case Diagrams, Data Flow Diagrams, and Activity Diagrams. The system developed achieves 4 stages of digital transformation in the PPIC process: digitalization, data integration, and process automation.

"

"Praktik kerja profesi yang dilaksanakan di PT. Taisho Pharmaceutical Indonesia, Tbk., Suku Dinas Kesehatan Kota Administrasi Jakarta Timur, dan Apotek Safa bertujuan untuk mengetahui tugas dan tanggung jawab seorang apoteker di industri farmasi, suku dinas kesehatan, dan di apotek. Selain itu, calon apoteker juga dapat memiliki gambaran nyata tentang permasalahan pekerjaan kefarmasian, memiliki wawasan, pengetahuan, keterampian, dan pengalaman praktis untuk melakukan pekerjaan kefarmasian.

---

Internship that be held at PT. Taisho Pharmaceutical Indonesia, Tbk., Suku Dinas Kesehatan Kota Administrasi Jakarta Timur, and Apotek Safa aims to understand the duties and responsibilities of pharmacists in the pharmaceutical factory, suku dinas kesehatan, and in the drugstore. In addition, the pharmacist candidatecan also have the insight, knowledge, skills, and practical experience to undertake pharmaceutical work."